Csrwin~ The AD trial was originally planned with FDA approval as per - placebo, 5mg and 10mg. Around 100 patients for each arm. It nearly took them 12 months to work out that they didn’t have enough cash. So they had to raise and revert back to Xanadu part 2. If the depression trial meets end points and proof of concept additional cash will be sought at a higher SP hopefully and the AD trial will be expanded. He/him.
- Forums
- ASX - By Stock
- Ann: Positive Xanamem brain PET study peer-reviewed publication
Csrwin~ The AD trial was originally planned with FDA approval as...
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.001(3.23%) |
Mkt cap ! $74.46M |
Open | High | Low | Value | Volume |
3.1¢ | 3.4¢ | 3.0¢ | $76.06K | 2.382M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10424 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 499999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10424 | 0.031 |
5 | 2091395 | 0.030 |
7 | 2120008 | 0.029 |
11 | 2112903 | 0.028 |
5 | 304148 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 499999 | 1 |
0.033 | 80000 | 2 |
0.034 | 230000 | 3 |
0.035 | 1052084 | 4 |
0.036 | 111133 | 2 |
Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
3.2¢ |
  |
Change
0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
3.2¢ | 3.4¢ | 3.1¢ | 1013448 | ||
Last updated 15.55pm 07/05/2024 ? |
Featured News
ACW (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online